News

bioMerieux has entered into an agreement with GlaxoSmithKline (GSK) to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer

The RealTime ready Influenza A/H1N1 Detection Set is used in conjunction with the RealTime ready RNA Virus Master kit also provided by Roche. The assay is carried out

Novartis has signed an agreement with Sarawak Biodiversity Centre (SBC) and BiotechCorp to discover bioactive compounds. Alexander Jetzer-Chung, director of Novartis said that the memorandum of understanding (MoU)

Appian Labs has entered an exclusive development and commercial license agreement for AppiForm Modular Release System with Capsugel. The agreement provides for Capsugel to utilise the AppiForm Modular

Abbott Laboratories (Abbott) has received a warning from the US regulators as it fails to follow good manufacturing practices (GMPs) standards at its Des Plaines facility, reported Daily

Microbix Biosystems has entered into a marketing and supply agreement with Riso Pharma for Kinlytic vials over the next three years. Kinlytic (Urokinase) is Microbix’ thrombolytic agent for

Broncus Technologies (Broncus) has reported early results of a double-blinded, randomised, sham-controlled EASE (Exhale Airway Stents for Emphysema) trial, for patients with emphysema/COPD. Airway Bypass is a minimally-invasive

Sinovac Biotech (Sinovac) has received a revised production license from State Food and Drug Administration (SFDA) for Panflu.1, the company’s H1N1 vaccine. Reportedly, with the revised license, the

Galapagos has started a Phase II clinical study to evaluate Nanocort’s effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and